Surgical treatment in patients with symptomatic PAD
When should a patient with symptoms of peripheral artery disease (PAD) be referred for interventional or surgical treatment?
When should a patient with symptoms of peripheral artery disease (PAD) be referred for interventional or surgical treatment?
What should be the duration of dual antiplatelet therapy in patients after percutaneous coronary interventions (PCIs)?
What is the current role of anticoagulation in patients with peripheral artery disease (PAD)?
Why was the new definition of myocardial infarction (MI) necessary? What have we learned about MI since the third definition?
What has changed in the 2018 European Society of Cardiology (ESC)/European Society of Hypertension (ESH) guidelines on hypertension?
Many patients on long-term antihypertensive treatment consider follow-up visits unnecessary as long as their home blood pressure measurements are normal and drugs can be ordered by phone. Are follow-up visits really needed?
Should we prescribe low-dose acetylsalicylic acid (ASA) for all patients with stable coronary disease?
Should all patients after myocardial infarction receive an angiotensin-converting enzyme (ACE) inhibitor?
Is it currently recommended to measure the uric acid level in blood and reduce it pharmacologically as part of cardiovascular disease prevention?
How to adjust the level of exercise in a patient with heart failure?